StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MeiraGTx's price to sales ratio was 2.3× on Nov 11, 2026, against 24.4× a year earlier. Over the last 5 years it ranged from 2.2× to 51.5×, with a median of 19.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.3×−21.0
2025Dec 31, 202523.3×−10.6
2024Dec 31, 202434.0×+25.1
2023Jan 31, 20238.8×+1.9
2022Dec 30, 20226.9×−44.6
2021Dec 31, 202151.5×+20.4
2020Dec 31, 202031.1×–

More MeiraGTx figures

See a number that looks wrong?